Robert B Wilsterman, MD - Medicare Orthopaedic Surgery in Falmouth, MA

Robert B Wilsterman, MD is a medicare enrolled "Orthopaedic Surgery" physician in Falmouth, Massachusetts. His current practice location is 5 Bramblebush Park, Falmouth, Massachusetts. You can reach out to his office (for appointments etc.) via phone at (508) 548-9423.

Robert B Wilsterman is licensed to practice in Massachusetts (license number 80345) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1609804632.

Contact Information

Robert B Wilsterman, MD
5 Bramblebush Park,
Falmouth, MA 02540-2325
(508) 548-9423
(508) 548-5239



Physician's Profile

Full NameRobert B Wilsterman
GenderMale
SpecialityOrthopaedic Surgery
Location5 Bramblebush Park, Falmouth, Massachusetts
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1609804632
  • Provider Enumeration Date: 06/29/2006
  • Last Update Date: 07/11/2016
  Medicare PECOS Information:
  • PECOS PAC ID: 3870541550
  • Enrollment ID: I20050110000526

Medical Identifiers

Medical identifiers for Robert B Wilsterman such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1609804632NPI-NPPES
103249400OtherMAOWCP
J14844OtherMABLUE SHIELD NO
171098OtherHARVARD PILGRIM
200037348OtherRR MEDICARE
080345OtherTUFTS HEALTH PLAN
043464579OtherSTANDARD TAX ID NO
000000029156OtherBMC HEALTHNET
0900520OtherUNITED HEALTHCARE
3131581MedicaidMA
B20808901OtherCIGNA

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207X00000XOrthopaedic Surgery 80345 (Massachusetts)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Robert B Wilsterman allows following entities to bill medicare on his behalf.
Entity NameMedical Affiliates Of Cape Cod Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1770534927
PECOS PAC ID: 3577471564
Enrollment ID: O20040510001010

News Archive

Cipher Pharmaceuticals to defend alleged patent infringement of CIP-TRAMADOL ER

Cipher Pharmaceuticals Inc. today announced that Purdue Pharma Products L.P. and Napp Pharmaceutical Group Ltd. have filed a complaint against Cipher in the United States District Court for the Eastern District of Virginia, for alleged infringement of two U.S. patents. The action relates to Cipher's New Drug Application ("NDA") filed with the U.S. Food and Drug Administration ("FDA") for CIP TRAMADOL ER, the Company's extended-release tramadol product.

KIKA provides Veracity advanced EDC platform for Clinical Asset Management

KIKA Clinical Solutions will welcome customers and partners who are driving the adoption of EDC for clinical trials at its second annual U.S. User Group Meeting in Boston, Mass., October 19 and 20. KIKA provides the Veracity advanced EDC platform for Clinical Asset Management to the pharmaceutical, biotechnology and medical device industries.

Shimadzu announces release of new Cannabis Analyzer for Potency at Pittcon 2017

Shimadzu Scientific Instruments (SSI) announces the release of its new Cannabis Analyzer for Potency. This high performance liquid chromatograph (HPLC) is the first-ever instrument designed specifically for quantitative determination of cannabinoid content. With the Cannabis Analyzer for Potency, operators are now able to produce accurate results with ease, regardless of cannabis testing knowledge or chromatography experience.

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Bayer Inc. today responded to Professor Marvin Meyer's letter to the editor, entitled: "Critical questions concerning the validity of the Bayer study report of differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration" and published in the online edition of the International Journal of Clinical Pharmacology and Therapeutics. Bayer responded to the clinical relevance of the differences in formulation and dissolution behaviour and the delayed absorption of Mylan's extended release nifedipine.

Alimera Sciences prices initial common stock public offering at $11.00 per share

Alimera Sciences, Inc. today announced that it priced its initial public offering of 6,550,000 shares of common stock at a price to the public of $11.00 per share on Wednesday, April 21, 2010.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robert B Wilsterman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Robert B Wilsterman, MD
5 Bramblebush Park,
Falmouth, MA 02540-2325

Ph: (508) 548-9423
Robert B Wilsterman, MD
5 Bramblebush Park,
Falmouth, MA 02540-2325

Ph: (508) 548-9423

News Archive

Cipher Pharmaceuticals to defend alleged patent infringement of CIP-TRAMADOL ER

Cipher Pharmaceuticals Inc. today announced that Purdue Pharma Products L.P. and Napp Pharmaceutical Group Ltd. have filed a complaint against Cipher in the United States District Court for the Eastern District of Virginia, for alleged infringement of two U.S. patents. The action relates to Cipher's New Drug Application ("NDA") filed with the U.S. Food and Drug Administration ("FDA") for CIP TRAMADOL ER, the Company's extended-release tramadol product.

KIKA provides Veracity advanced EDC platform for Clinical Asset Management

KIKA Clinical Solutions will welcome customers and partners who are driving the adoption of EDC for clinical trials at its second annual U.S. User Group Meeting in Boston, Mass., October 19 and 20. KIKA provides the Veracity advanced EDC platform for Clinical Asset Management to the pharmaceutical, biotechnology and medical device industries.

Shimadzu announces release of new Cannabis Analyzer for Potency at Pittcon 2017

Shimadzu Scientific Instruments (SSI) announces the release of its new Cannabis Analyzer for Potency. This high performance liquid chromatograph (HPLC) is the first-ever instrument designed specifically for quantitative determination of cannabinoid content. With the Cannabis Analyzer for Potency, operators are now able to produce accurate results with ease, regardless of cannabis testing knowledge or chromatography experience.

Bayer's Adalat XL product and Mylan's nifedipine extended release 60 mg not bioequivalent: Study

Bayer Inc. today responded to Professor Marvin Meyer's letter to the editor, entitled: "Critical questions concerning the validity of the Bayer study report of differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration" and published in the online edition of the International Journal of Clinical Pharmacology and Therapeutics. Bayer responded to the clinical relevance of the differences in formulation and dissolution behaviour and the delayed absorption of Mylan's extended release nifedipine.

Alimera Sciences prices initial common stock public offering at $11.00 per share

Alimera Sciences, Inc. today announced that it priced its initial public offering of 6,550,000 shares of common stock at a price to the public of $11.00 per share on Wednesday, April 21, 2010.

Read more News

› Verified 7 days ago


Orthopaedic Surgery Doctors in Falmouth, MA

Paul M Dimond, M.D.
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 360 Gifford St, Falmouth, MA 02540
Phone: 508-457-4900    Fax: 508-457-4911
Lara H Baldasaro, PA
Orthopedic Surgery
Medicare: Accepting Medicare Assignments
Practice Location: 360 Gifford St, Falmouth, MA 02540
Phone: 508-457-4900    Fax: 508-457-4911
Dr. Bertrand Stevens Duncan, M.D.
Orthopedic Surgery
Medicare: Not Enrolled in Medicare
Practice Location: 100 Ter Heun Dr, Falmouth Hospital, Falmouth, MA 02540
Phone: 508-548-5300    Fax: 508-457-3955
Ralph Warren Cook Iv, MD
Orthopedic Surgery
Medicare: Medicare Enrolled
Practice Location: 360 Gifford St, Falmouth, MA 02540
Phone: 508-457-4900    
David F Gouveia, M.D.
Orthopedic Surgery
Medicare: Medicare Enrolled
Practice Location: 100 Ter Heun Dr, Falmouth, MA 02540
Phone: 508-548-3699    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.